Robust SARS-CoV-2 antibody and T cell immunity following three COVID-19 vaccine doses in inflammatory bowel disease patients receiving anti-TNF or alternative treatments
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2024 |
|---|---|
| Erschienen: |
2024 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:73 |
|---|---|
| Enthalten in: |
Gut - 73(2024), 4 vom: 07. März, Seite 712-714 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Zhang, Eva [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Antibodies, Viral |
|---|
| Anmerkungen: |
Date Completed 11.03.2024 Date Revised 11.03.2024 published: Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1136/gutjnl-2022-329136 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM353845043 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM353845043 | ||
| 003 | DE-627 | ||
| 005 | 20240311231825.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2024 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1136/gutjnl-2022-329136 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1323.xml |
| 035 | |a (DE-627)NLM353845043 | ||
| 035 | |a (NLM)36878683 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Zhang, Eva |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Robust SARS-CoV-2 antibody and T cell immunity following three COVID-19 vaccine doses in inflammatory bowel disease patients receiving anti-TNF or alternative treatments |
| 264 | 1 | |c 2024 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 11.03.2024 | ||
| 500 | |a Date Revised 11.03.2024 | ||
| 500 | |a published: Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 650 | 4 | |a Letter | |
| 650 | 4 | |a COVID-19 | |
| 650 | 4 | |a IMMUNE RESPONSE | |
| 650 | 4 | |a IMMUNOLOGY | |
| 650 | 4 | |a INFLAMMATORY BOWEL DISEASE | |
| 650 | 4 | |a TNF | |
| 650 | 7 | |a COVID-19 Vaccines |2 NLM | |
| 650 | 7 | |a Tumor Necrosis Factor Inhibitors |2 NLM | |
| 650 | 7 | |a Antibodies, Viral |2 NLM | |
| 700 | 1 | |a Nguyen, Thi H O |e verfasserin |4 aut | |
| 700 | 1 | |a Allen, Lilith F |e verfasserin |4 aut | |
| 700 | 1 | |a Kedzierski, Lukasz |e verfasserin |4 aut | |
| 700 | 1 | |a Rowntree, Louise C |e verfasserin |4 aut | |
| 700 | 1 | |a Chang, So Young |e verfasserin |4 aut | |
| 700 | 1 | |a Zhang, Wuji |e verfasserin |4 aut | |
| 700 | 1 | |a Habel, Jennifer R |e verfasserin |4 aut | |
| 700 | 1 | |a Foo, Isabelle J |e verfasserin |4 aut | |
| 700 | 1 | |a Menon, Tejas |e verfasserin |4 aut | |
| 700 | 1 | |a Mitchell, Jeni |e verfasserin |4 aut | |
| 700 | 1 | |a Leong, Rupert W |e verfasserin |4 aut | |
| 700 | 1 | |a Bond, Katherine |e verfasserin |4 aut | |
| 700 | 1 | |a Williamson, Deborah A |e verfasserin |4 aut | |
| 700 | 1 | |a Kedzierska, Katherine |e verfasserin |4 aut | |
| 700 | 1 | |a Christensen, Britt |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Gut |d 1960 |g 73(2024), 4 vom: 07. März, Seite 712-714 |w (DE-627)NLM000003557 |x 1468-3288 |7 nnns |
| 773 | 1 | 8 | |g volume:73 |g year:2024 |g number:4 |g day:07 |g month:03 |g pages:712-714 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1136/gutjnl-2022-329136 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 73 |j 2024 |e 4 |b 07 |c 03 |h 712-714 | ||